Sport Investors League
  • Politics
  • Stocks
  • Investing
  • Business

Sport Investors League

  • Politics
  • Stocks
  • Investing
  • Business
Business

McKinsey & Co. to pay $650M to settle opioid consulting probe, ex-partner to plead guilty

by admin December 17, 2024
December 17, 2024
McKinsey & Co. to pay $650M to settle opioid consulting probe, ex-partner to plead guilty

McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company’s consulting work advising Purdue Pharma on how to increase sales of its opioid painkiller OxyContin, a court filing said Friday.

A former top partner at McKinsey, Martin Elling, also agreed to plead guilty to obstruction of justice next month in the probe by the U.S. Department of Justice, according to a filing in U.S. District Court in Abingdon, Virginia.

The criminal charging document that McKinsey agreed to have filed by prosecutors alleges the consulting giant “knowingly and intentionally” conspired with Purdue Pharma “and others to aid and abet the misbranding of prescription drugs.”

The document also said McKinsey is accused, through the acts of its then-partner Elling, of “knowingly destroying and concealing records and documents with the intent” to impede the investigation by the Department of Justice.

McKinsey, which previously agreed to pay almost $1 billion to settle lawsuits by states, local governments and others related to its opioid consulting, accepted responsibility for the conduct alleged by federal prosecutors, according to the deferred prosecution agreement.

As part of the deal, McKinsey will not work on any marketing, sale, promotion or distribution of controlled substances.

In a statement to CNBC, McKinsey said, “We are deeply sorry for our past client service to Purdue Pharma and the actions of a former partner who deleted documents related to his work for that client.”

“We should have appreciated the harm opioids were causing in our society and we should not have undertaken sales and marketing work for Purdue Pharma,” the firm said. “This terrible public health crisis and our past work for opioid manufacturers will always be a source of profound regret for our firm has requested comment from McKinsey.”

The company said that in addition to its deferred prosecution agreement with the DOJ, it “has agreed to settle a related civil False Claims Act investigation and to enter into a Corporate Integrity Agreement with the Office of Inspector General at the Department of Health and Human Services.”

This post appeared first on NBC NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
From Chili’s to burger chains, here are the restaurant industry winners and losers in 2024
next post
Uranium Price 2024 Year-End Review

Related Posts

Sam Altman tells OpenAI staff there’s no plan...

October 1, 2024

Trump says it’s ‘highly unlikely’ he will fire...

July 18, 2025

Trump Media CFO, two other insiders sell millions...

November 16, 2024

Amazon extends Prime Day discounts to 4 days...

July 10, 2025

Biden preparing to block U.S. Steel sale to...

September 6, 2024

Walmart fined for shipping realistic toy guns to...

May 29, 2025

Super Micro’s $50 billion stock collapse underscores risk...

November 2, 2024

U.S. markets close sharply lower — but some...

August 7, 2024

Amazon plans to launch discount store in bid...

June 28, 2024

As inflation cools, Social Security could pay out...

July 12, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent

    • Key aide in IRS’ Tea Party targeting controversy put on leave after allegations of new anti-GOP effort

      August 6, 2025
    • Supreme Court orders new arguments in pivotal elections case

      August 6, 2025
    • Michelle Obama celebrates Barack as ‘coolest guy’ on his birthday after the pair joked about divorce rumors

      August 6, 2025
    • Senate GOP ready to go nuclear after Schumer’s ‘political extortion’ of nominees

      August 6, 2025
    • Cotton calls on IRS to pull Muslim advocacy group’s nonprofit status

      August 6, 2025

    Categories

    • Business (1,052)
    • Investing (2,769)
    • Politics (3,407)
    • Stocks (1,155)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sportinvestorsleague.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 sportinvestorsleague.com | All Rights Reserved